Answers are grounded in this paper and cite their sources.
During the COVID-19 pandemic, the healthcare system faced a number of problems related to socioeconomic factors, particularly in providing medical care to the population. The economic damage inflicted on the healthcare system was associated with the need to provide high-tech medical care to patients both in the acute and delayed periods, especially in cases of a severe disease with multiorgan involvement requiring urgent inotropic and vasopressor support in the intensive care unit (ICU) — multisystem inflammatory syndrome (MIS). The complexity of providing medical care to children with MIS lies in the differential diagnosis with Kawasaki disease and infectious diseases accompanied by sepsis, which clinical symptoms are similar. Therefore, it is relevant to search for genetic determinants for the early assessment of predisposition and subsequent clinical-laboratory monitoring of patients at potential risk of developing MIS after having contracted the novel coronavirus infection, especially among children. Whole exome sequencing (WES) was performed on patients diagnosed with multisystem inflammatory syndrome (8 patients), Kawasaki disease (2 patients), and infectious diseases accompanied by sepsis (5 patients). As a result, pathogenic/likely pathogenic genetic variants were identified that could have influenced the development of the disease and its course. Genetic data were correlated with clinical manifestations and laboratory test results. As a result of the study, common genetic variants were found in patients: PEX5: NM_001300789.1:c.210+77_210+121del(); MUC5AC: M_001304359.2:c.1987T>C(NP_001291288.1:p.Ser663Pro), NM_001304359.2:c.1993A>G(NP_001291288.1:p.Thr665Ala) and NM_001304359.2: c.2290A>G(NP_001291288.1:p.Thr764Ala), which may indicate similarities in the molecular-genetic mechanisms of the studied pathologies. Unique variants were also identified for different disease groups. These observations directly point to the necessity of widespread implementation of personalized medical-genetic approaches to understand the probable risks of complications followed after infectious diseases and possible responses to treatment strategies.
No takes yet. Share an insight, caveat, or question.
Владимировна et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: